section name header

Indications

BEERS REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension.

Derm: ERYTHEMA MULTIFORME, photosensitivity, pruritus, rash, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, urticaria.

EENT: hearing loss, tinnitus.

Endo: hypercholesterolemia, hyperglycemia, hypertriglyceridemia, hyperuricemia.

F and E: dehydration, hypocalcemia, hypochloremia, hypokalemia, hypomagnesemia, hyponatremia, hypovolemia, metabolic alkalosis.

GI: ↑ liver enzymes, anorexia, constipation, diarrhea, dry mouth, dyspepsia, nausea, pancreatitis, vomiting.

GU: ↑ BUN, excessive urination, nephrocalcinosis.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, hemolytic anemia, leukopenia, thrombocytopenia.

MS: muscle cramps.

Neuro: blurred vision, dizziness, headache, paresthesia, vertigo.

Misc: fever.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

Edema

Hypertension

US Brand Names

Furoscix, Lasix

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: diuretics

Pharmacologic Classification: loop diuretics

Pharmacokinetics

Absorption: 60–67% absorbed after oral administration (↓ in acute HF and in renal failure); also absorbed from IM sites; IV administration results in complete availability; 99.6% absorbed after subcut administration.

Distribution: Crosses placenta, enters breast milk.

Protein Binding: 91–99%.

Metabolism/Excretion: Minimally metabolized by liver, some nonhepatic metabolism, some renal excretion as unchanged drug.

Half-life: 30–120 min (↑ in renal impairment).

Time/Action Profile

(diuretic effect)

ROUTEONSETPEAKDURATION
PO30–60 min1–2 hr6–8 hr
IM10–30 minunknown4–8 hr
IV5 min30 min2 hr
Subcutunknownunknown8 hr

Patient/Family Teaching

Pronunciation

fur-OH-se-mide audio

Pill Image

furosemide_195_9157.jpg

Code

NDC Code*